Following the all-stock transaction, currently expected to close in Q2 2023, Adaptimmune shareholders will own ~75% and TCR² Therapeutics stockholders will own ~25% of the combined company Companies ...
MONACO, June 16, 2023 (GLOBE NEWSWIRE) -- Cadeler A/S (OSE: CADLR) (“Cadeler”) and Eneti Inc. (NETI) (“Eneti”), two offshore wind turbine and foundation installation companies, announce today that ...
In conjunction with the business combination agreement, the parties have several local and international commitments for new investments by institutional investors, including Digital Assets and ...
METUCHEN, N.J. & CLEARWATER, Fla.--(BUSINESS WIRE)--Fortune Rise Acquisition Corporation (Nasdaq: FRLA) and OriginClear Inc. (OTC Other: OCLN), the Clean Water Innovation Hub™, today announced that ...